Allergodyl (Azelastine) eye drops 0.05% 6 ml.

active substances: azelastine hydrochloride;

1 ml of solution contains azelastine hydrochloride 0.5 mg;

excipients: hypromellose, disodium edetate, benzalkonium chloride, sorbitol crystallizing solution, sodium hydroxide, water for injections.

Drugs used in ophthalmology. Anti-edematous and anti-allergic agents. ATX code S01G X07.

Azelastine is a phthalazinone derivative of the structure, with a prolonged anti-allergic effect, selectively blocks H1-receptors. When applied to the mucous membrane of the eye, azelastine also has an anti-inflammatory effect.

Azelastine inhibits the synthesis or release of chemical mediators involved in the early and late stages of allergic reactions, such as leukotrienes, histamine, platelet-activating factor (PAF) inhibitors, and serotonin.

Evaluation of the ECG of patients who used large doses of azelastine for a long time shows the absence of a clinically significant effect of azelastine on the QT (QTc) interval.

There was no association between azelastine use and ventricular arrhythmias or ventricular flutter and fibrillation in patients receiving oral azelastine.

Treatment and prevention of symptoms of seasonal allergic conjunctivitis in adults and children aged 4 years and older.

Treatment of symptoms of year-round (non-seasonal) allergic conjunctivitis in adults and children over 12 years of age.

Hypersensitivity to any components of the drug.

Seasonal allergic conjunctivitis. Unless otherwise prescribed, the dose for adults and children over 4 years of age is 1 drop in each eye 2 times a day. If necessary, the dose can be increased up to 4 times a day. In the case of the expected effect of the allergen, the drug should be used for preventive purposes before contact with the allergen.

Year-round (non-seasonal) allergic conjunctivitis. Unless otherwise prescribed, the dose for adults and children over 12 years of age is 1 drop in each eye 2 times a day. If necessary, the dose can be increased up to 4 times a day. The duration of treatment should not usually exceed 6 weeks.

The patient should keep in mind that the use of the drug for more than 6 weeks should be under the supervision of a doctor, even in the treatment of seasonal allergic conjunctivitis.